From: Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm
Medical history | In association with |
---|---|
Conditions associated with low numbers of follicles at birth/menarche | Turner syndrome – associated with POF/POI |
Idiopathic/genetics – association? | |
Excessive recruitment | FMR1 mutations |
Premutation range (CGGn=55–200) – associated with POF/POI | |
Monoalleleic low sub-genotype – associated with POA/OPOI | |
Biallelic low sub-genotype – associated with POA/OPOI | |
AMHR2 gene – associated with POF/POI | |
AIRE gene – associated with POF/POI | |
Other genetic causes | BRCA1 mutations – associated with POA/OPOI |
Space occupying lesions and Iatrogenic factors -mostly associated with POF/POI but also with POA/OPOI | Ovarian surgery |
Chemotherapy | |
Radiation therapy | |
Bone marrow transplantation | |
Other medical risk factors | Endometriosis – associated with POA/OPOI |
Polycystic ovarian syndrome (PCOS) – associated with POA/OPOI | |
>>> > in association with low FMR1 mutations and risk further augmented in presence of autoimmunity | |
Autoimmunity –mostly associated with POA/OPOI but also with POF/POI | Thyroid autoimmunity |
Adrenal autoimmunity | |
Any other autoimmunity | |
Autoimmune polyglandular syndromes | |
Family history of autoimmune disease* | |
History of repeated pregnancy loss | |
Early history of maternal/sibling menopause | Â |